Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TADreg: a versatile regression framework for TAD identification, differential analysis and rearranged 3D genome prediction. | BMC Bioinformatics | 2022 | 35236295 | PubTator, text mining | PubMed |
| 10 Years of GWAS discovery in endometrial cancer: Aetiology, function and translation. | EBioMedicine | 2022 | 35219087 | PubTator, text mining | PubMed |
| Bioengineered Efficacy Models of Skin Disease: Advances in the Last 10 Years. | Pharmaceutics | 2022 | 35214050 | PubTator, text mining | PubMed |
| The Pseudokinase TRIB1 in Immune Cells and Associated Disorders. | Cancers (Basel) | 2022 | 35205759 | PubTator, text mining | PubMed |
| Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression. | Cancers (Basel) | 2022 | 35205716 | PubTator, text mining | PubMed |
| The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy. | Hemasphere | 2022 | 35198856 | PubTator, text mining | PubMed |
| Comparison of transcriptome profiles of nucleated red blood cells in cord blood between preterm and full-term neonates. | Hematology | 2022 | 35192776 | PubTator, text mining | PubMed |
| Human dendritic cell subsets: An updated view of their ontogeny and functional specialization. | Eur J Immunol | 2022 | 35187651 | PubTator, text mining | PubMed |
| CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation. | Int J Mol Sci | 2022 | 35163006 | PubTator, text mining | PubMed |
| Thalassemia and erythroid transcription factor KLF1 mutations associated with borderline hemoglobin A2 in the Thai population. | Arch Med Sci | 2022 | 35154532 | PubTator, text mining | PubMed |
| Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. | Elife | 2022 | 35147495 | PubTator, text mining | PubMed |
| Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively. | Diagn Pathol | 2022 | 35144623 | PubTator, text mining | PubMed |
| Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia. | Gene | 2022 | 35143940 | PubTator, text mining | PubMed |
| RNA-Seq of Single Fish Cells - Seeking Out the Leukocytes Mediating Immunity in Teleost Fishes. | Front Immunol | 2022 | 35140719 | PubTator, text mining | PubMed |
| Human transcription factor protein interaction networks. | Nat Commun | 2022 | 35140242 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of human colonic macrophages reveals niche-specific subsets. | J Exp Med | 2022 | 35139155 | PubTator, text mining | PubMed |
| ZMIZ2 promotes the development of triple-receptor negative breast cancer. | Cancer Cell Int | 2022 | 35101047 | PubTator, text mining | PubMed |
| CRISPR/Cas9-based multiplex genome editing of BCL11A and HBG efficiently induces fetal hemoglobin expression. | Eur J Pharmacol | 2022 | 35093321 | PubTator, text mining | PubMed |
| Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression. | Blood | 2022 | 35090172 | PubTator, text mining | PubMed |
| Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple-negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta. | Clin Transl Med | 2022 | 35090098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=44